Quality of Active versus Spontaneous Reporting of Adverse Drug Reactions in Pediatric Patients: Relevance for Pharmacovigilance and Knowledge in Pediatric Medical Care

For drug safety in pediatric patients, knowledge about adverse drug reactions (ADRs) is essential to balance benefits and risks, especially because of the high incidence of off-label drug use. However, underreporting of ADRs is a serious problem, leading to a deficit in knowledge affecting clinical...

Full description

Bibliographic Details
Main Authors: Anne T. M. Dittrich, Nori J. L. Smeets, Emma F. M. de Jong, Juliët L. Kämink, Yvet Kroeze, Jos M. Th. Draaisma, Eugène P. van Puijenbroek, D. Maroeska W. M. te Loo
Format: Article
Language:English
Published: MDPI AG 2022-09-01
Series:Pharmaceuticals
Subjects:
Online Access:https://www.mdpi.com/1424-8247/15/9/1148
_version_ 1827657870955511808
author Anne T. M. Dittrich
Nori J. L. Smeets
Emma F. M. de Jong
Juliët L. Kämink
Yvet Kroeze
Jos M. Th. Draaisma
Eugène P. van Puijenbroek
D. Maroeska W. M. te Loo
author_facet Anne T. M. Dittrich
Nori J. L. Smeets
Emma F. M. de Jong
Juliët L. Kämink
Yvet Kroeze
Jos M. Th. Draaisma
Eugène P. van Puijenbroek
D. Maroeska W. M. te Loo
author_sort Anne T. M. Dittrich
collection DOAJ
description For drug safety in pediatric patients, knowledge about adverse drug reactions (ADRs) is essential to balance benefits and risks, especially because of the high incidence of off-label drug use. However, underreporting of ADRs is a serious problem, leading to a deficit in knowledge affecting clinical practice. The aim of this study is to find a method by which we can improve the quantity of ADR reporting while maintaining or improving the quality of the ADR reports. This was done in several steps. First, health care providers were educated to increase awareness of ADRs. Thereafter, a novel active supporting system was introduced, where reporting ADRs was simplified; if clinical physicians suspected an ADR, they only had to send the name or hospital number of the patient, the observed ADR, and the suspected drug to a supportive team. This team collects all information needed about the possible ADR from the patient’s medical records and hospital charts. With this information, the supportive team fills in the forms necessary for reporting ADRs to the nationwide pharmacovigilance centre Lareb. With this system, the quantity of ADR reports from both inpatients and outpatients rose dramatically. Subsequently, the quality of the obtained ADR reports was measured using the ClinDoc and vigiGrade systems. This study shows there is no loss of quality of the ADR reports in the active reporting system compared to spontaneous reporting systems. Based on the data of the present study, we suggest that an active reporting system has the potential to increase our knowledge about ADRs in pediatric patients.
first_indexed 2024-03-09T22:50:59Z
format Article
id doaj.art-148aef8c56994023940649287268e2a6
institution Directory Open Access Journal
issn 1424-8247
language English
last_indexed 2024-03-09T22:50:59Z
publishDate 2022-09-01
publisher MDPI AG
record_format Article
series Pharmaceuticals
spelling doaj.art-148aef8c56994023940649287268e2a62023-11-23T18:19:34ZengMDPI AGPharmaceuticals1424-82472022-09-01159114810.3390/ph15091148Quality of Active versus Spontaneous Reporting of Adverse Drug Reactions in Pediatric Patients: Relevance for Pharmacovigilance and Knowledge in Pediatric Medical CareAnne T. M. Dittrich0Nori J. L. Smeets1Emma F. M. de Jong2Juliët L. Kämink3Yvet Kroeze4Jos M. Th. Draaisma5Eugène P. van Puijenbroek6D. Maroeska W. M. te Loo7Department of Pediatrics, Radboud University Medical Centre, Radboud Institute for Health Sciences, Amalia Children’s Hospital, 6500 HB Nijmegen, The NetherlandsDepartment of Pharmacology and Toxicology, Radboud University Medical Centre, Radboud Institute for Health Sciences, 6500 HB Nijmegen, The NetherlandsDepartment of Pediatrics, Radboud University Medical Centre, Radboud Institute for Health Sciences, Amalia Children’s Hospital, 6500 HB Nijmegen, The NetherlandsDepartment of Pediatrics, Radboud University Medical Centre, Radboud Institute for Health Sciences, Amalia Children’s Hospital, 6500 HB Nijmegen, The NetherlandsDepartment of Pediatrics, Radboud University Medical Centre, Radboud Institute for Health Sciences, Amalia Children’s Hospital, 6500 HB Nijmegen, The NetherlandsDepartment of Pediatrics, Radboud University Medical Centre, Radboud Institute for Health Sciences, Amalia Children’s Hospital, 6500 HB Nijmegen, The NetherlandsNetherlands Pharmacovigilance Centre Lareb, 5237 MH ‘s-Hertogenbosch, The NetherlandsDepartment of Pharmacology and Toxicology, Radboud University Medical Centre, Radboud Institute for Health Sciences, 6500 HB Nijmegen, The NetherlandsFor drug safety in pediatric patients, knowledge about adverse drug reactions (ADRs) is essential to balance benefits and risks, especially because of the high incidence of off-label drug use. However, underreporting of ADRs is a serious problem, leading to a deficit in knowledge affecting clinical practice. The aim of this study is to find a method by which we can improve the quantity of ADR reporting while maintaining or improving the quality of the ADR reports. This was done in several steps. First, health care providers were educated to increase awareness of ADRs. Thereafter, a novel active supporting system was introduced, where reporting ADRs was simplified; if clinical physicians suspected an ADR, they only had to send the name or hospital number of the patient, the observed ADR, and the suspected drug to a supportive team. This team collects all information needed about the possible ADR from the patient’s medical records and hospital charts. With this information, the supportive team fills in the forms necessary for reporting ADRs to the nationwide pharmacovigilance centre Lareb. With this system, the quantity of ADR reports from both inpatients and outpatients rose dramatically. Subsequently, the quality of the obtained ADR reports was measured using the ClinDoc and vigiGrade systems. This study shows there is no loss of quality of the ADR reports in the active reporting system compared to spontaneous reporting systems. Based on the data of the present study, we suggest that an active reporting system has the potential to increase our knowledge about ADRs in pediatric patients.https://www.mdpi.com/1424-8247/15/9/1148drug safetyadverse drug reactionspharmacovigilanceactive reporting ADRsquality of ADR reports
spellingShingle Anne T. M. Dittrich
Nori J. L. Smeets
Emma F. M. de Jong
Juliët L. Kämink
Yvet Kroeze
Jos M. Th. Draaisma
Eugène P. van Puijenbroek
D. Maroeska W. M. te Loo
Quality of Active versus Spontaneous Reporting of Adverse Drug Reactions in Pediatric Patients: Relevance for Pharmacovigilance and Knowledge in Pediatric Medical Care
Pharmaceuticals
drug safety
adverse drug reactions
pharmacovigilance
active reporting ADRs
quality of ADR reports
title Quality of Active versus Spontaneous Reporting of Adverse Drug Reactions in Pediatric Patients: Relevance for Pharmacovigilance and Knowledge in Pediatric Medical Care
title_full Quality of Active versus Spontaneous Reporting of Adverse Drug Reactions in Pediatric Patients: Relevance for Pharmacovigilance and Knowledge in Pediatric Medical Care
title_fullStr Quality of Active versus Spontaneous Reporting of Adverse Drug Reactions in Pediatric Patients: Relevance for Pharmacovigilance and Knowledge in Pediatric Medical Care
title_full_unstemmed Quality of Active versus Spontaneous Reporting of Adverse Drug Reactions in Pediatric Patients: Relevance for Pharmacovigilance and Knowledge in Pediatric Medical Care
title_short Quality of Active versus Spontaneous Reporting of Adverse Drug Reactions in Pediatric Patients: Relevance for Pharmacovigilance and Knowledge in Pediatric Medical Care
title_sort quality of active versus spontaneous reporting of adverse drug reactions in pediatric patients relevance for pharmacovigilance and knowledge in pediatric medical care
topic drug safety
adverse drug reactions
pharmacovigilance
active reporting ADRs
quality of ADR reports
url https://www.mdpi.com/1424-8247/15/9/1148
work_keys_str_mv AT annetmdittrich qualityofactiveversusspontaneousreportingofadversedrugreactionsinpediatricpatientsrelevanceforpharmacovigilanceandknowledgeinpediatricmedicalcare
AT norijlsmeets qualityofactiveversusspontaneousreportingofadversedrugreactionsinpediatricpatientsrelevanceforpharmacovigilanceandknowledgeinpediatricmedicalcare
AT emmafmdejong qualityofactiveversusspontaneousreportingofadversedrugreactionsinpediatricpatientsrelevanceforpharmacovigilanceandknowledgeinpediatricmedicalcare
AT julietlkamink qualityofactiveversusspontaneousreportingofadversedrugreactionsinpediatricpatientsrelevanceforpharmacovigilanceandknowledgeinpediatricmedicalcare
AT yvetkroeze qualityofactiveversusspontaneousreportingofadversedrugreactionsinpediatricpatientsrelevanceforpharmacovigilanceandknowledgeinpediatricmedicalcare
AT josmthdraaisma qualityofactiveversusspontaneousreportingofadversedrugreactionsinpediatricpatientsrelevanceforpharmacovigilanceandknowledgeinpediatricmedicalcare
AT eugenepvanpuijenbroek qualityofactiveversusspontaneousreportingofadversedrugreactionsinpediatricpatientsrelevanceforpharmacovigilanceandknowledgeinpediatricmedicalcare
AT dmaroeskawmteloo qualityofactiveversusspontaneousreportingofadversedrugreactionsinpediatricpatientsrelevanceforpharmacovigilanceandknowledgeinpediatricmedicalcare